Literature DB >> 2894807

Spastic paraparesis and HTLV-I infection in Peru.

R T Johnson1, D E Griffin, A Arregui, C Mora, C J Gibbs, J M Cuba, L Trelles, A Vaisberg.   

Abstract

Three of 6 patients with spastic paraparesis in Lima, Peru, were found to have antibodies to human T-lymphotropic virus type I (HTLV-I). Blood and cerebrospinal fluid antibodies were confirmed by Western blot analysis. Multilobulated lymphocytes in blood and cerebrospinal fluid of the index case stained with monoclonal antibodies for T-helper cells and for T10, an activation marker. Blood mononuclear cells from patients with HTLV-I-associated myelopathy showed spontaneous proliferation in culture, evidence of interleukin-2 receptors, and decreased natural killer cell activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894807     DOI: 10.1002/ana.410230734

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

1.  Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type I.

Authors:  P S Sarin; P Rodgers-Johnson; D K Sun; A H Thornton; O S Morgan; W N Gibbs; C Mora; G McKhann; D C Gajdusek; C J Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

2.  High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru.

Authors:  Jorge O Alarcón; Heidi B Friedman; Silvia M Montano; Joseph R Zunt; King K Holmes; Gerald V Quinnan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

Review 3.  Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum.

Authors:  P E Rodgers-Johnson
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.